Go Deep
Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,939 | 8.6 | 1.73 | 0.00 | 890.94 |
Cipher Pharmaceuticals Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 12,067,000.0 | 12,505,000.0 | 12,218,000.0 | 12,833,000.0 |
| Net Profit | 4,013,000.0 | 6,163,000.0 | 13,311,000.0 | 5,501,000.0 |
| EPS | 0.2 | 0.2 | — | 0.2 |
Cipher Pharmaceuticals Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 50,451,000.0 | 33,363,000.0 | 21,162,000.0 | 20,675,000.0 | — |
| Net Profit | 27,329,000.0 | 11,545,000.0 | 20,383,000.0 | 26,636,000.0 | — |
| EPS | 1.1 | 0.5 | 0.8 | 1.1 | — |
Cipher Pharmaceuticals Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 156,502,000.0 | 162,512,000.0 | 86,031,000.0 | 73,776,000.0 | — |
| Total Liabilities | 30,258,000.0 | 60,169,000.0 | 5,511,000.0 | 9,696,000.0 | — |
| Total Equity | 126,244,000.0 | 102,343,000.0 | 80,520,000.0 | 64,080,000.0 | — |
Cipher Pharmaceuticals Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 4.8%Receivables 7.2%Inventory 5.2%Intangible assets 57.2%Other assets 25.3%
How it's funded — Dec 2025
Long-term debt 3.2%Payables 4.1%Other liabilities 11.9%Shareholders' equity 80.7%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 7.5 | 17.8 | 39.8 | 28.8 |
| Receivables | 11.2 | 13.9 | 5.1 | 6.8 |
| Inventory | 8.2 | 5.8 | 3.0 | 2.2 |
| Fixed assets (tangible) | 0.6 | 0.7 | 0.4 | 0.5 |
| Intangible assets | 89.5 | 96.2 | 17.5 | 18.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 39.6 | 28.1 | 20.3 | 17.0 |
| Liabilities & equity | ||||
| Short-term debt | 0.3 | 0.3 | 0.1 | 0.1 |
| Long-term debt | 5.0 | 40.0 | 0.3 | 0.3 |
| Payables | 6.4 | 5.9 | 4.6 | 4.1 |
| Other liabilities | 18.6 | 14.0 | 0.6 | 5.2 |
| Shareholders' equity | 126.2 | 102.3 | 80.5 | 64.1 |
| Net tangible assets | 36.8 | 6.1 | 63.1 | 45.6 |
Cipher Pharmaceuticals Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 29,726,000.0 | 19,546,000.0 | 15,999,000.0 | 10,725,000.0 | — |
| Investing Activities | -71,000.0 | -80,044,000.0 | -144,000.0 | -81,000.0 | — |
| Financing Activities | -40,472,000.0 | 39,296,000.0 | -5,244,000.0 | -1,912,000.0 | — |